Download PDF
Klin Monbl Augenheilkd 2007; 224(12): 900-904
DOI: 10.1055/s-2007-963693
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Die Kombination von Pharmakologie und Vitrektomie kann die Grenzen der mechanischen vitreoretinalen Chirurgie überwinden

The Need for Pharmacology in Vitreoretinal SurgerySOE Lecture 2007A. Gandorfer1
  • 1Vitreoretinal and Pathology Unit, Augenklinik der Ludwig-Maximilians-Universität München
Further Information

Publication History

Eingegangen: 15.10.2007

Angenommen: 22.10.2007

Publication Date:
18 December 2007 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund: Trotz aller technischer Entwicklungen, welche die Vitrektomie in den 35 Jahren seit ihrer Erfindung zu einem hoch effektiven und sicheren Routineverfahren der intraokularen Chirurgie werden ließen, stößt die mechanische Glaskörperentfernung und Manipulation der Netzhaut an ihre Grenzen. Material und Methoden: Durch die Zusammenschau klinischer und pathologischer, meist ultrastruktureller Befunde werden die Grenzen der Vitrektomie aufgezeigt und Lösungsansätze aktueller und zukünftiger Forschungsaktivitäten vorgestellt. Ergebnisse: Die Grenzen der Vitrektomie sind: 1. Inkomplette Glaskörperentfernung. 2. Therapie von Spätstadien. 3. Fehlende Neuroprotektion. 4. Ungenügend sicher definierte Dissektionsebenen. Diese Grenzen lassen sich nur in Kombination der Chirurgie mit der Pharmakologie überwinden. Schlussfolgerungen: Folgende Forschungs- und Lösungsansätze werden vorgestellt: Ad 1. Pharmakologische Vitreolyse. Ad 2. Frühere, weniger traumatische Intervention. Ad 3. Neuroprotektion und antiproliferative Substanzen. Ad 4. Selektive Anfärbung von Glaskörperrinde und ILM.

Abstract

Background: While the limits of mechanical vitrectomy are being approached, scientists and vitreoretinal surgeons are looking for a combination of pharmacology and vitrectomy, i. e., pharmacology-assisted vitrectomy. Methods: This review shows the limits of conventional vitreoretinal surgery by presenting clinical and ultrastructural data related to vitreoretinal surgical techniques and outcomes. Results: The limits of conventional vitreoretinal surgery include: 1. Incomplete vitreous cortex removal. 2. Surgery of advanced stages of the disease. 3. The lack of neuroprotection and antiproliferative agents. 4. Ill-defined cleavage planes when removing tissue from the retina. Conclusions: Pharmacology-assisted vitrectomy helps to overcome the limits of conventional vitreoretinal surgery by addressing: Item 1. Pharmacological vitreolysis. Item 2. Earlier, less traumatic intervention. Item 3. Neuroprotection and antiproliferative agents. Item 4. Selective staining of distinct structures of the vitreoretinal interface, such as cortical vitreous, cellular proliferation, and internal limiting membrane.

Schlüsselwörter

Glaskörper - Pathologie - Retina

Key words

pathology - retina - vitreous

Literatur

  • 1 Ansari R R, Suh K I, Sebag J. Dynamic light scattering (DLS) quantifies the effects of microplasmin pharmacologic vitreolysis. Poster at the 5th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT). Monte Carlo; 2004
    Google Scholar
  • 2 Bonnet M. The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.  Graefes Arch Clin Exp Ophthalmol. 1988;  226 (3) 201-205
    Google Scholar
  • 3 Capeans C, Lorenzo J, Santos L. et al . Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy.  Graefes Arch Clin Exp Ophthalmol. 1998;  236 (7) 481-485
    Google Scholar
  • 4 Charteris D G, Sethi C S, Lewis G P. et al . Proliferative vitreoretinopathy: developments in adjunctive treatment and retinal pathology.  Eye. 2002;  16 369-374
    Google Scholar
  • 5 Eibl K H, Lewis G P, Betts K. et al . The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment.  Invest Ophthalmol Vis Sci. 2007;  48 (3) 1305-1311
    Google Scholar
  • 6 Faulborn J, Bowald S. Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: corresponding light and electron microscopic studies.  Graefes Arch Clin Exp Ophthalmol. 1985;  223 (3) 130-138
    Google Scholar
  • 7 Foos R Y. Vitreoretinal juncture; topographical variations.  Invest Ophthalmol Vis Sci. 1972;  11 (10) 801-808
    Google Scholar
  • 8 Gandorfer A. Pharmacologic vitreolysis.  Dev Ophthalmol. 2007;  39 149-56
    Google Scholar
  • 9 Gandorfer A, Messmer E M, Ulbig M W. et al . Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.  Retina. 2000;  20 (2) 126-133
    Google Scholar
  • 10 Gandorfer A, Priglinger S, Schebitz K. et al . Vitreoretinal morphology of plasmin-treated human eyes.  Am J Ophthalmol. 2002;  133 (1) 156-159
    Google Scholar
  • 11 Gandorfer A, Putz E, Welge-Lussen U. et al . Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.  Br J Ophthalmol. 2001;  85 (1) 6-10
    Google Scholar
  • 12 Gandorfer A, Rohleder M, Charteris D. et al . Ultrastructure of vitreomacular traction syndrome associated with persistent hyaloid artery.  Eye. 2005;  19 (3) 333-336
    Google Scholar
  • 13 Gandorfer A, Rohleder M, Charteris D G. et al . Staining and peeling of the internal limiting membrane in the cat eye.  Curr Eye Res. 2005;  30 (11) 977-987
    Google Scholar
  • 14 Gandorfer A, Rohleder M, Grosselfinger S. et al . Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.  Am J Ophthalmol. 2005;  139 (4) 638-652
    Google Scholar
  • 15 Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome.  Br J Ophthalmol. 2002;  86 (8) 902-909
    Google Scholar
  • 16 Gandorfer A, Rohleder M, Sethi C. et al . Posterior vitreous detachment induced by microplasmin.  Invest Ophthalmol Vis Sci. 2004;  45 (2) 641-647
    Google Scholar
  • 17 Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants.  Eye. 2002;  16 (1) 95-97
    Google Scholar
  • 18 Gauthier R, Joly S, Pernet V. et al . Brain-derived neurotrophic factor gene delivery to muller glia preserves structure and function of light-damaged photoreceptors.  Invest Ophthalmol Vis Sci. 2005;  46 (9) 3383-3392
    Google Scholar
  • 19 Hageman G S, Russell S R. Chondroitinase-mediated disinsertion of the primate vitreous body.  Invest Ophthalmol Vis Sci. 1994;  35 1260
    Google Scholar
  • 20 Haritoglou C, Gass C A, Kristin N. et al . Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole.  British Journal of Ophthalmology. 2001;  85 231-233
    Google Scholar
  • 21 Haritoglou C, Reiniger I W, Schaumberger M. et al . Five-year follow-up of macular hole surgery with peeling of the internal limiting membrane: update of a prospective study.  Retina. 2006;  26 (6) 618-622
    Google Scholar
  • 22 Haritoglou C, Schumann R, Reiniger I. et al . Evaluation of the internal limiting membrane after conventional peeling during macular hole surgery.  Retina. 2006;  26 (1) 21-24
    Google Scholar
  • 23 Haritoglou C, Tadayoni R, May C A. et al . Short-term in vivo evaluation of novel vital dyes for intraocular surgery.  Retina. 2006;  26 (6) 673-678
    Google Scholar
  • 24 Kampik A, Green W R, Michels R G. et al . Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery.  Am J Ophthalmol. 1980;  90 (6) 797-809
    Google Scholar
  • 25 Kampik A, Kenyon K R, Michels R G. et al . Epiretinal and vitreous membranes. Comparative study of 56 cases.  Arch Ophthalmol. 1981;  99 (8) 1445-1454
    Google Scholar
  • 26 Kohno T, Sorgente N, Ishibashi T. et al . Immunofluorescent studies of fibronectin and laminin in the human eye.  Invest Ophthalmol Vis Sci. 1987;  28 (3) 506-514
    Google Scholar
  • 27 Kuppermann B D, Thomas E L, Smet M D. et al . Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.  Am J Ophthalmol. 2005;  140 (4) 573-584
    Google Scholar
  • 28 Kuppermann B D, Thomas E L, Smet de M D. et al . Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.  Am J Ophthalmol. 2005;  140 (4) 585-597
    Google Scholar
  • 29 Lewis G P, Charteris D G, Sethi C S. et al . The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment.  Invest Ophthalmol Vis Sci. 2002;  43 (7) 2412-2420
    Google Scholar
  • 30 Lewis G P, Guerin C J, Anderson D H. et al . Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment.  Am J Ophthalmol. 1994;  118 (3) 368-376
    Google Scholar
  • 31 Lewis G P, Linberg K A, Geller S F. et al . Effects of the neurotrophin brain-derived neurotrophic factor in an experimental model of retinal detachment.  Invest Ophthalmol Vis Sci. 1999;  40 (7) 1530-1544
    Google Scholar
  • 32 Lewis G P, Sethi C S, Linberg K A. et al . Experimental retinal reattachment: a new perspective.  Mol Neurobiol. 2003;  28 (2) 159-175
    Google Scholar
  • 33 Machemer de R, Norton E W. A new concept for vitreous surgery. Indications and results.  Am J Ophthalmol. 1972;  74 (6) 1034-1056
    Google Scholar
  • 34 Machemer R, Norton E W. Vitrectomy, a pars plana approach. II Clinical experience.  Mod Probl Ophthalmol. 1972;  10 178-185
    Google Scholar
  • 35 Machemer R, Parel J M, Norton E W. Vitrectomy: a pars plana approach. Technical improvements and further results.  Trans Am Acad Ophthalmol Otolaryngol. 1972;  76 (2) 462-466
    Google Scholar
  • 36 Margherio A R, Margherio R R, Hartzer M. et al . Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes.  Ophthalmology. 1998;  105 (9) 1617-1620
    Google Scholar
  • 37 Schumann R G, Schaumberger M M, Rohleder M. et al . Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases.  Am J Ophthalmol. 2006;  141 (6) 1112-1119
    Google Scholar
  • 38 Schwartz S D, Alexander R, Hiscott P. et al . Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.  Ophthalmology. 1996;  103 (2) 323-328
    Google Scholar
  • 39 Stefansson E, Landers III M B, Wolbarsht M L. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy.  Trans Am Ophthalmol Soc. 1981;  79 307-334
    Google Scholar
  • 40 Stefansson E, Landers III M B, Wolbarsht M L. Vitrectomy, lensectomy, and ocular oxygenation.  Retina. 1982;  2 (3) 159-166
    Google Scholar
  • 41 Tezel T H, Del Priore L V, Kaplan H J. Posterior vitreous detachment with dispase.  Retina. 1998;  18 (1) 7-15
    Google Scholar
  • 42 Trese M. Enzymatic-assisted vitrectomy.  Eye. 2002;  16 365-368
    Google Scholar
  • 43 Verma L, Prakash G, Tewari H K. Diabetic retinopathy: time for action.  No complacency please! Bull World Health Organ. 2002;  80 (5) 419
    Google Scholar
  • 44 Verstraeten T C, Chapman C, Hartzer M. et al . Pharmacologic induction of posterior vitreous detachment in the rabbit.  Arch Ophthalmol. 1993;  111 (6) 849-854
    Google Scholar
  • 45 Williams J G, Trese M T, Williams G A. et al . Autologous plasmin enzyme in the surgical management of diabetic retinopathy.  Ophthalmology. 2001;  108 (10) 1902-1905
    Google Scholar

Priv.-Doz. Dr. A. Gandorfer

Vitreoretinal and Pathology Unit, Universitäts-Augenklinik München

Mathildenstr. 8

80336 München

Phone: ++ 49/89/51 60 38 56

Fax: ++ 49/89/51 60 47 78

Email: arnd.gandorfer@med.uni-muenchen.de

      >